Evidence map›Paper›PMID 33360636›Full record

ArticleThrombosis research2021

Platelet electrical resistance for measuring platelet activation and adhesion in human health and disease.

Travis M Griffiths, Lauren Page, Andrew S Weyrich, Matthew T Rondina, Robert A Campbell

Open access · greenAbstract read
In one paragraph

Article in Thrombosis research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Travis M GriffithsUniversity of Utah Molecular Medicine Program, Salt Lake City, UT 84112, United States of America.
Lauren PageUniversity of Utah Molecular Medicine Program, Salt Lake City, UT 84112, United States of America.
Andrew S WeyrichUniversity of Utah Molecular Medicine Program, Salt Lake City, UT 84112, United States of America; Department of Internal Medicine, University of Utah, Salt Lake City, UT 84132, United States of America.
Matthew T RondinaUniversity of Utah Molecular Medicine Program, Salt Lake City, UT 84112, United States of America; Department of Internal Medicine, University of Utah, Salt Lake City, UT 84132, United States of America; George E. Wahlen VAMC Department of Internal Medicine and GRECC, Salt Lake City, UT 84148, United States of America; Department of Pathology, University of Utah, Salt Lake City, UT 84132, United States of America.
Robert A CampbellUniversity of Utah Molecular Medicine Program, Salt Lake City, UT 84112, United States of America; Department of Internal Medicine, University of Utah, Salt Lake City, UT 84132, United States of America. Electronic address: rcampbell@u2m2.utah.edu.
University of Utah · USGeriatric Research Education and Clinical Center · US

Funding

Utah Center for Clinical and Translational ScienceUL1TR002538 · NCATS · UNIVERSITY OF UTAH · PI HESS, RACHEL, MAJERSIK, JENNIFER JUHL · 2018 to 2022
$26.0M
Translational Research Skills Development CoreU54HL112311 · NHLBI · UNIVERSITY OF UTAH · PI WEYRICH, ANDREW S, ZIMMERMAN, GUY A. · 2012 to 2016
$12.9M
Translational Control of Megakaryocyte and Platelet Gene Expression in DiseaseR35HL145237 · NHLBI · UNIVERSITY OF UTAH · PI WEYRICH, ANDREW S · 2019 to 2025
$4.7M
The Effects of ART on Platelets and HIV-Associated ThrombosisR01HL126547 · NHLBI · UNIVERSITY OF UTAH · PI PLANELLES, VICENTE, RONDINA, MATTHEW THOMAS · 2014 to 2017
$3.0M
Translational Control of Megakaryocyte and Platelet Function in SepsisR01HL142804 · NHLBI · UNIVERSITY OF UTAH · PI RONDINA, MATTHEW THOMAS · 2018 to 2021
$1.9M
UT StrokeNetU10NS086606 · NINDS · UNIVERSITY OF UTAH · PI MAJERSIK, JENNIFER JUHL · 2013 to 2017
$1.8M
Platelet Immune Responses in Aging and InfluenzaR01AG048022 · NIA · UNIVERSITY OF UTAH · PI RONDINA, MATTHEW THOMAS · 2014 to 2018
$1.8M
Interferon-Induced Transmembrane Protein 3 (IFITM3) Regulates Thrombosis During Inflammation in AgingK01AG059892 · NIA · UNIVERSITY OF UTAH · PI CAMPBELL, ROBERT A · 2019 to 2022
$400k
Novel Regulatory Mechanisms of Inflammation-Induced ThrombosisR56AG059877 · NIA · UNIVERSITY OF UTAH · PI RONDINA, MATTHEW THOMAS · 2018 to 2018
$381k
Platelet Reprogramming During InflammationI01CX001696 · VA · VA SALT LAKE CITY HEALTHCARE SYSTEM · PI Matthew Thomas Rondina · 2018 to 2026
–
CSRD VA I01 CX001696NCATS NIH HHS UL1 TR002538NHLBI NIH HHS R01 HL126547NHLBI NIH HHS R01 HL142804NHLBI NIH HHS R35 HL145237NHLBI NIH HHS U54 HL112311NIA NIH HHS K01 AG059892NIA NIH HHS R01 AG048022NIA NIH HHS R56 AG059877NINDS NIH HHS U10 NS086606
6 · The paper itself

Abstract

backgroundThe ability to measure changes in platelet reactivity is important to identify novel aspects of platelet biology and develop targeted therapeutics to prevent bleeding or thrombosis. Current platelet function testing allows for single agonist analysis at a time. The ability to phenotype platelets in a single assay with multiple agonists and adhesion substrates could yield more insights into altered pathways than are feasible with current approaches. We hypothesized platelet electrical resistance (PER) could be used for more comprehensive phenotyping of platelets.

methodsPlatelets were isolated from male and female healthy donors (age 39.6 ± 6.9) and septic patients (age 44.0 ± 13.5). PER 96-well plates were coated with various substrates, including fibrinogen and collagen. Platelets were added to the coated plates in the presence or absence of thrombin or convulxin. Platelet activation and spreading was monitored by measuring changes in electrical impedance.

resultsPlatelets adhesion to fibrinogen and collagen increased impedance. In addition, impedance increased in response to thrombin or convulxin. No changes in impedance were observed in the absence of platelets or when wells were uncoated, indicating changes in impedance were directly due to platelet adhesion and activation. Inhibiting integrin αIIbβ3 decreased impedance when fibrinogen was used as a substrate, consistent with platelet-dependent effects. Platelets from septic patients caused increased impedance compared to healthy donors, demonstrating this assay can be used to assess platelet hyperreactivity.

conclusionPER can be applied as a high throughput tool to measure platelet reactivity in health and disease, where platelet activation is increased.

Indexed as

Blood PlateletsPlatelet ActivationAdultElectric ImpedanceFemaleFibrinogenHumansMaleMiddle AgedPlatelet AdhesivenessPlatelet AggregationPlatelet Glycoprotein GPIIb-IIIa ComplexFibrinogenPlatelet Glycoprotein GPIIb-IIIa Complex

Identifiers

PMID33360636
PMCPMC7867577
OpenAlexW3114005265

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.